ESCAPE-NEXT Trial
ESCAPE-NEXT is a multicentre, randomized, double-blinded, placebo-controlled, parallel Group, singledose trial designed to determine the efficacy and safety of nerinetide in participants with acute ischemic stroke undergoing endovascular thrombectomy excluding thrombolysis.
ESCAPE-NEXT is a custom designed Electronic Data Capture (EDC), Randomization and Drug Management (RDM) Interactive Resposive Technology (IRT) developed for the purpose of facilitating the data collection for the ESCAPE-NEXT Trial, while providing the following functions:
- Enables randomization of subjects based on a minimal sufficient balance algorithm
- Provides the ability to record and store patient profiles
- Provides drug management capabilities across multiple sites/locations
- Provides functionality for validating the randomization of subjects
- Provides an API integration with the IBM EDC solution
- Provides a finance module for generating invoices based on patient enrollment and follow-up visits during the trial
- Dashboards, charts and reports
- Secure & Scalable
Other Links:
Ready to build?Get started today.
At heart, we are a dynamic and open-minded group of individuals that want to help companies succeed. First and foremost, we are critical thinkers and problem solvers.
Contact Us